Pembrolizumab monoclonal antibody drug. Targets Programmed cell Death 1 (PD-1) and is used in the treatment of cancer (immune checkpoint inhibitor). Generic name and stylized antibody representation.
Tags
antibody biological biosimilar biotech biotechnology blockade blocker cancer cell checkpoint death disease drug immune immuno-oncology immunoglobulin immunology immunotherapy infusion inhibitor injection inn lambrolizumab lung lymphocyte mab melanoma metastasis metastatic monoclonal nomenclature nsclc pd-1 pembrolizumab peptide programmed protein receptor t-cell
-
50
-
0
License and Use
Free for commercial use No attribution required
- Created With Redmond.ai
- Details
- Published on Nov 09, 2022
- Photo type JPG
- Category Science